Management of Lactic Acidosis in Acute Liver Failure and Critical Illness
Diagnostic Work‑up for Acute Liver Failure (ALF)
- Impaired hepatic lactate clearance in ALF is a primary mechanism for severe lactic acidosis. 1, 2
- Initial evaluation should include acetaminophen level, hepatitis A IgM, hepatitis B surface antigen and anti‑HBc IgM, toxicology screen (amphetamines, cocaine), hepatic Doppler ultrasound, and transthoracic echocardiography. 1, 3
- Baseline coagulation (PT/INR, factor V), arterial blood gas with lactate, arterial ammonia, and glucose are essential laboratory studies. 1, 2
Immediate Therapeutic Measures for Suspected ALF
- Administer intravenous N‑acetylcysteine immediately, irrespective of the presumed etiology of ALF. 1, 2
- Early notification of a liver transplant center is recommended. 1, 2
- If herpes simplex virus infection is clinically suspected (e.g., fever), start empiric acyclovir. 1, 2
- Perform rapid assessment of encephalopathy, hemodynamic status, and renal function. 1
Metformin‑Associated Lactic Acidosis
- Metformin is contraindicated in patients with advanced renal insufficiency or impaired hepatic function because of a heightened risk of lactic acidosis. 4, 5
- Discontinuation of metformin should be immediate in the setting of liver disease. 4, 5
Acid‑Base Management
- Sodium bicarbonate should not be used for lactic acidosis when arterial pH is ≥ 7.15, as it offers no hemodynamic benefit and may cause harm. 6, 7, 8
- Evidence shows bicarbonate does not improve vasopressor requirements or tissue perfusion in hypoperfusion‑related lactic acidosis. 7, 8
- Potential adverse effects of bicarbonate therapy include sodium/fluid overload, increased lactate and PaCO₂, and reduced ionized calcium. 7, 8
- Bicarbonate may be considered only when pH falls below 7.15; however, supporting data are limited. 7, 8
Respiratory Support in Severe Dyspnea
- Apply a lung‑protective ventilatory strategy if endotracheal intubation is required. 3, 2
- Systematically evaluate volume status, cardiac output, and right‑ and left‑sided cardiac function. 3, 2
- Crystalloid fluids are the first‑line choice for volume expansion. 3, 2
- Initiate norepinephrine infusion for refractory hypotension. 3, 2
Renal Replacement Therapy (RRT)
- Indications for RRT are limited to definitive clinical needs such as severe hyper‑kalemia, uremia, or refractory volume overload. 6, 7, 8
- RRT should not be employed solely to treat lactic acidosis or an isolated rise in creatinine without other indications. 7, 8
- Continuous RRT modalities are preferred when fluid balance management is required in hemodynamically unstable patients. 6, 7
Monitoring and Prognostic Indicators in ALF
- Frequent neurologic monitoring; intubate if the Glasgow Coma Scale falls below 8. 3, 2
- Maintain serum sodium within 140–145 mmol/L. 3, 2
- Check blood glucose at least every 2 hours. 3, 2
- Initiate empirical broad‑spectrum antibiotics when encephalopathy worsens or systemic inflammatory response syndrome develops. 3, 2
- Do not use lactulose or rifaximin to lower ammonia levels in ALF. 3
- Routine correction of coagulopathy is unnecessary unless active bleeding is present. 3
- Avoid nephrotoxic agents, including non‑steroidal anti‑inflammatory drugs. 3
Prognostic Lactate Thresholds
- Lactate concentrations > 9 mmol/L are linked to extremely poor outcomes and may serve as a contraindication to liver transplantation. 9
- Lactate levels > 4 mmol/L are associated with adverse post‑transplant outcomes. 9
- Additional poor‑prognosis markers include PaO₂/FiO₂ < 150, escalating vasopressor support, and dependence on mechanical ventilation. 9, 10